Polycomb repressive complex 2 mutations predict survival benefit in advanced cancer patients treated with immune checkpoint inhibitors

被引：0
|
作者：
Vlachostergios, P. J. [1 ]
机构：
[1] Weill Cornell Med, Hematol & Med Oncol, New York, NY USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.01.035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21P
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [21] Risk factors for pneumonitis in advanced extrapulmonary cancer patients treated with immune checkpoint inhibitors
    Uchida, Yasuki
    Kinose, Daisuke
    Nagatani, Yukihiro
    Tanaka-Mizuno, Sachiko
    Nakagawa, Hiroaki
    Fukunaga, Kentaro
    Yamaguchi, Masafumi
    Nakano, Yasutaka
    BMC CANCER, 2022, 22 (01)
  • [22] Risk factors for pneumonitis in advanced extrapulmonary cancer patients treated with immune checkpoint inhibitors
    Yasuki Uchida
    Daisuke Kinose
    Yukihiro Nagatani
    Sachiko Tanaka-Mizuno
    Hiroaki Nakagawa
    Kentaro Fukunaga
    Masafumi Yamaguchi
    Yasutaka Nakano
    BMC Cancer, 22
  • [23] Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients
    Mocan, Eda Eylemer
    Yekeduz, Emre
    Karatas, Gokturk
    Yazgan, Sati Coskun
    Koksoy, Elif Berna
    Senler, Filiz Cay
    Utkan, Gungor
    Demirkazik, Ahmet
    Akbulut, Hakan
    Urun, Yuksel
    ANTI-CANCER DRUGS, 2024, 35 (02) : 190 - 194
  • [24] Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors
    Yekeduz, Emre
    Koksoy, Elif Berna
    Yazgan, Sati Coskun
    Karatas, Gokturk
    Senler, Filiz Cay
    Utkan, Gungor
    Akbulut, Hakan
    Demirkazik, Ahmet
    Urun, Yuksel
    ANTI-CANCER DRUGS, 2022, 33 (10) : 1145 - 1149
  • [25] Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors
    Li, Nijiao
    Zheng, Xuliang
    Gan, Jinyan
    Zhuo, Ting
    Li, Xiaohong
    Yang, Chuyi
    Wu, Yanbin
    Qin, Shouming
    CHINESE MEDICAL JOURNAL, 2023, 136 (21) : 2562 - 2572
  • [26] Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
    Spillane, Susan
    Baxi, Shrujal
    Torres, Aracelis Z.
    Lenis, David
    Freedman, Andrew N.
    Mariotto, Angela B.
    Sharon, Elad
    ONCOLOGIST, 2020, 25 (11): : E1753 - E1762
  • [27] Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors
    Li Nijiao
    Zheng Xuliang
    Gan Jinyan
    Zhuo Ting
    Li Xiaohong
    Yang Chuyi
    Wu Yanbin
    Qin Shouming
    中华医学杂志英文版, 2023, 136 (21)
  • [28] Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors
    Chen, Ning
    Yu, Ying
    Shen, Wanji
    Xu, Xiaoling
    Fan, Yun
    CLINICAL NUTRITION, 2024, 43 (01) : 142 - 153
  • [29] The prognostic role of "drug score" on the outcome of advanced cancer patients treated with immune checkpoint inhibitors
    Perrone, F.
    Bersanelli, M.
    Cortellini, A.
    Casartelli, C.
    Bordi, P.
    Tiseo, M.
    Buti, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S714 - S715
  • [30] Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors
    Peyraud, F.
    Guegan, J. -P.
    Bodet, D.
    Nafia, I.
    Fontan, L.
    Auzanneau, C.
    Cousin, S.
    Roubaud, G.
    Cabart, M.
    Chomy, F.
    Le Loarer, F.
    Chaput, N.
    Danlos, F. -X.
    Planchard, D.
    Even, C.
    Khettab, M.
    Tselikas, L.
    Besse, B.
    Barlesi, F.
    Soria, J. -C.
    Marabelle, A.
    Bessede, A.
    Italiano, A.
    ANNALS OF ONCOLOGY, 2022, 33 (10) : 1041 - 1051
12345